Insmed Valuation

INSM Stock  USD 24.16  0.37  1.51%   
At this time, the firm appears to be overvalued. Insmed Inc retains a regular Real Value of $21.21 per share. The prevalent price of the firm is $24.16. Our model calculates the value of Insmed Inc from evaluating the firm fundamentals such as Return On Equity of -14.53, return on asset of -0.32, and Current Valuation of 4.36 B as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Insmed's valuation include:
Price Book
25.4507
Enterprise Value
4.4 B
Enterprise Value Ebitda
(6.78)
Price Sales
13.2635
Enterprise Value Revenue
14.6561
Overvalued
Today
24.16
Please note that Insmed's price fluctuation is not too volatile at this time. Calculation of the real value of Insmed Inc is based on 3 months time horizon. Increasing Insmed's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Insmed Inc is useful when determining the fair value of the Insmed stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Insmed. Since Insmed is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Insmed Stock. However, Insmed's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  24.16 Real  21.21 Target  42.58 Hype  24.16 Naive  23.56
The real value of Insmed Stock, also known as its intrinsic value, is the underlying worth of Insmed Inc Company, which is reflected in its stock price. It is based on Insmed's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Insmed's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Insmed's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
21.21
Real Value
26.58
Upside
Estimating the potential upside or downside of Insmed Inc helps investors to forecast how Insmed stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Insmed more accurately as focusing exclusively on Insmed's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
-1.38-1.14-0.97
Details
Hype
Prediction
LowEstimatedHigh
21.9224.1626.40
Details
Naive
Forecast
LowNext ValueHigh
21.3323.5625.80
Details
17 Analysts
Consensus
LowTarget PriceHigh
38.7542.5847.26
Details
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Insmed's intrinsic value based on its ongoing forecasts of Insmed's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Insmed's closest peers. When choosing an evaluation method for Insmed Inc, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.

Insmed Investments

(194.84 Million)

Insmed Valuation Trend

Knowing Insmed's actual value is paramount for traders to make sound investment determinations. Insmed's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Insmed's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Insmed's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.

Insmed Market Cap

Insmed Inc is currently regarded as number one stock in market capitalization category among related companies. Market capitalization of Health Care industry is currently estimated at about 3.95 Billion. Insmed totals roughly 3.65 Billion in market capitalization claiming about 92% of equities under Health Care industry.
Capitalization  Revenue  Workforce  Valuation  Total debt

Insmed Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Insmed's current stock value. Our valuation model uses many indicators to compare Insmed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Insmed competition to find correlations between indicators driving Insmed's intrinsic value. More Info.
Insmed Inc is rated second overall in price to earning category among related companies. It is rated second overall in price to book category among related companies . As of the 23rd of May 2024, Price To Book Ratio is likely to grow to -12.46. Comparative valuation analysis is a catch-all model that can be used if you cannot value Insmed by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Insmed's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Insmed's earnings, one of the primary drivers of an investment's value.

Insmed's Earnings Breakdown by Geography

Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Insmed's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Insmed and how it compares across the competition.

About Insmed Valuation

The stock valuation mechanism determines the current worth of Insmed Inc on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Insmed Inc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Insmed Inc based exclusively on its fundamental and basic technical indicators. By analyzing Insmed's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Insmed's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Insmed. We calculate exposure to Insmed's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Insmed's related companies.
Last ReportedProjected for Next Year
Gross Profit239.6 M251.6 M
Pretax Profit Margin(2.45)(2.57)
Operating Profit Margin(2.33)(2.44)
Net Loss(2.46)(2.58)
Gross Profit Margin 0.79  0.82 

8 Steps to conduct Insmed's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Insmed's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Insmed's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Insmed's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Insmed's revenue streams: Identify Insmed's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Insmed's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Insmed's growth potential: Evaluate Insmed's management, business model, and growth potential.
  • Determine Insmed's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Insmed's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Insmed Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Insmed does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding140.4 M

Insmed Current Valuation Indicators

Valuation refers to the process of determining the present value of Insmed Inc and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Insmed we look at many different elements of the entity such as Insmed's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Insmed's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Insmed's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Insmed, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Insmed's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Insmed's worth.
When determining whether Insmed Inc is a strong investment it is important to analyze Insmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insmed's future performance. For an informed investment choice regarding Insmed Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insmed Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Complementary Tools for Insmed Stock analysis

When running Insmed's price analysis, check to measure Insmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insmed is operating at the current time. Most of Insmed's value examination focuses on studying past and present price action to predict the probability of Insmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insmed's price. Additionally, you may evaluate how the addition of Insmed to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Transaction History
View history of all your transactions and understand their impact on performance
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Is Insmed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.15)
Revenue Per Share
2.199
Quarterly Revenue Growth
0.158
Return On Assets
(0.32)
Return On Equity
(14.53)
The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.